In vitro experiments confirmed that the vaccine elicited IFN-γ+ T lymphocytes and produced cytokines such as IL-10, IFN-γ, IL-6, and TNF-α in individuals with different TB conditions such as HCs, ATB patients, and LTBI individuals. This evidence concerns the gene IL10 and tuberculosis.